Natalia Lazorko

1 та иш

Almazov National Medical Research Centre, St. Petersburg, Russian Federation

1. POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment

   Olga Kulemina, Julia Yakovleva, Natalia Lazorko +6

   МақолаChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.010138